Quarterly report pursuant to Section 13 or 15(d)

Aytu Divestiture - Summary of Income Statement (Details)

v3.20.1
Aytu Divestiture - Summary of Income Statement (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Other income (expense):    
Change in value of Guarantee $ 1,755,000 $ 0
Pediatric Portfolio | Discontinued Operations, Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Product revenue, net (717,342) 2,835,074
Operating expenses:    
Cost of product sales 0 1,195,344
General and administrative 0 41,374
Sales and marketing 0 2,712,626
Amortization expense 0 744,099
Change in fair value of contingent consideration 0 159,462
Total operating expenses 0 4,852,905
Other income (expense):    
Change in value of Guarantee 1,755,000 0
Interest expense, net 0 (238,158)
Total other income (expense) 1,755,000 (238,158)
Income (loss) from discontinued operations before tax 1,037,658 (2,255,989)
Income tax expense   35,685
Income (loss) from discontinued operations, net of tax $ 1,037,658 $ (2,291,674)